Formulation of PEGylated-liposome encapsulated glycopeptide antibiotics
US9566238B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2011 |
| Grant date | Feb 14, 2017 |
| Priority date | — |
| Expiry date | Sep 18, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K9/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to a novel method of treating an individual suffering from a bacterial infection, such as bacterial infections of various tissues or organs of an individual. In general, the method of treatment involves administering to an individual a pharmaceutical formulation that comprises a liposome-encapsulated antimicrobial agent, wherein polyethylene glycol (PEG) molecules are covalently attached to the surface of the liposomes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.